Viking Therapeutics Faces Setbacks Amid Weight Loss Drug Trials

This chapter examines the disappointing trial results for Viking Therapeutics and the subsequent decline in their stock value. It highlights the challenges faced due to severe side effects which impacted participant retention, while also discussing market implications in comparison to major competitors like Eli Lilly and Novo Nordisk.